OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Approach to Cognitive Impairment in Parkinson’s Disease
Qiang Zhang, Georgina M. Aldridge, Nandakumar S. Narayanan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1495-1510
Open Access | Times Cited: 54
Qiang Zhang, Georgina M. Aldridge, Nandakumar S. Narayanan, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 4, pp. 1495-1510
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
Transcranial Magnetic Stimulation in the Treatment of Neurological Diseases
Fahad Somaa, Tom A. de Graaf, Alexander T. Sack
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 82
Fahad Somaa, Tom A. de Graaf, Alexander T. Sack
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 82
Alpha-Synuclein Pre-Formed Fibrils Injected into Prefrontal Cortex Primarily Spread to Cortical and Subcortical Structures
Matthew A. Weber, Gemma Kerr, Ramasamy Thangavel, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 81-94
Open Access | Times Cited: 11
Matthew A. Weber, Gemma Kerr, Ramasamy Thangavel, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 81-94
Open Access | Times Cited: 11
Gray matter, white matter and cerebrospinal fluid abnormalities in Parkinson’s disease: A voxel-based morphometry study
Charles Okanda Nyatega, Qiang Li, Mohammed Jajere Adamu, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 36
Charles Okanda Nyatega, Qiang Li, Mohammed Jajere Adamu, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 36
Acupuncture for the Treatment of Neuropsychiatric Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis
Anxin Zhang, Zefeng Song, Anqi Di, et al.
Complementary Therapies in Medicine (2024) Vol. 80, pp. 103020-103020
Open Access | Times Cited: 7
Anxin Zhang, Zefeng Song, Anqi Di, et al.
Complementary Therapies in Medicine (2024) Vol. 80, pp. 103020-103020
Open Access | Times Cited: 7
Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1756-1756
Open Access | Times Cited: 14
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
Medicina (2023) Vol. 59, Iss. 10, pp. 1756-1756
Open Access | Times Cited: 14
A systematic review of the effectiveness of digital cognitive assessments of cognitive impairment in Parkinson’s disease
Susan R. Craig, Martin Dempster, David Curran, et al.
Applied Neuropsychology Adult (2025), pp. 1-13
Open Access
Susan R. Craig, Martin Dempster, David Curran, et al.
Applied Neuropsychology Adult (2025), pp. 1-13
Open Access
Efficacy of transcranial direct current stimulation on cognitive function in patients with Parkinson's disease: a systematic review and meta-analysis
S Ma, Weisheng Zhuang, Xu Wang, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
S Ma, Weisheng Zhuang, Xu Wang, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Emerging Role of Mesenchymal Stromal Cell and Exosome Therapies in Treating Cognitive Impairment
Vick Key Tew, Muttiah Barathan, Fazlina Nordin, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 284-284
Open Access
Vick Key Tew, Muttiah Barathan, Fazlina Nordin, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 284-284
Open Access
Multi-targeted benzylpiperidine–isatin hybrids: Design, synthesis, biological and in silico evaluation as monoamine oxidases and acetylcholinesterase inhibitors for neurodegenerative disease therapies
Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi
Journal of Computer-Aided Molecular Design (2025) Vol. 39, Iss. 1
Closed Access
Nikita Negi, Senthil Raja Ayyannan, Rati Kailash Prasad Tripathi
Journal of Computer-Aided Molecular Design (2025) Vol. 39, Iss. 1
Closed Access
Early Detection and Management of Cognitive Impairment in Parkinson's Disease: A Predictive Model Approach
Li Li, Shan Tang, Bin Hao, et al.
Brain and Behavior (2025) Vol. 15, Iss. 3
Open Access
Li Li, Shan Tang, Bin Hao, et al.
Brain and Behavior (2025) Vol. 15, Iss. 3
Open Access
Telemedicine and eHealth Solutions in Clinical Practice
Fabrizio Del Carpio Delgado, David Hugo Bernedo-Moreira, Antony Paul Espíritu-Martínez, et al.
EAI Endorsed Transactions on Pervasive Health and Technology (2023) Vol. 9
Open Access | Times Cited: 12
Fabrizio Del Carpio Delgado, David Hugo Bernedo-Moreira, Antony Paul Espíritu-Martínez, et al.
EAI Endorsed Transactions on Pervasive Health and Technology (2023) Vol. 9
Open Access | Times Cited: 12
Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks
Н Ю Новиков, E. S. Brazhnik, Valentina Kitchigina
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1890-1904
Closed Access | Times Cited: 11
Н Ю Новиков, E. S. Brazhnik, Valentina Kitchigina
Biochemistry (Moscow) (2023) Vol. 88, Iss. 11, pp. 1890-1904
Closed Access | Times Cited: 11
Polygenic Risk Scores Contribute to Personalized Medicine of Parkinson’s Disease
Mohammad Dehestani, Hui Liu, Thomas Gasser
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1030-1030
Open Access | Times Cited: 24
Mohammad Dehestani, Hui Liu, Thomas Gasser
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1030-1030
Open Access | Times Cited: 24
Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson’s disease
Shuyan Tong, Rui-Wen Wang, Qian Li, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
Shuyan Tong, Rui-Wen Wang, Qian Li, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease
Xi Chen, Yuhu Zhang
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 324-330
Open Access | Times Cited: 8
Xi Chen, Yuhu Zhang
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 324-330
Open Access | Times Cited: 8
Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition
Yi Jayne Tan, Isabel Siow, Seyed Ehsan Saffari, et al.
Journal of Alzheimer s Disease (2023) Vol. 92, Iss. 2, pp. 573-580
Closed Access | Times Cited: 7
Yi Jayne Tan, Isabel Siow, Seyed Ehsan Saffari, et al.
Journal of Alzheimer s Disease (2023) Vol. 92, Iss. 2, pp. 573-580
Closed Access | Times Cited: 7
A systematic review and network meta-analysis comparing various non-pharmacological treatments for older people with mild cognitive impairment
Yuanyuan Wang, Xiao-xian Wang, Lei Chen, et al.
Asian Journal of Psychiatry (2023) Vol. 86, pp. 103635-103635
Closed Access | Times Cited: 7
Yuanyuan Wang, Xiao-xian Wang, Lei Chen, et al.
Asian Journal of Psychiatry (2023) Vol. 86, pp. 103635-103635
Closed Access | Times Cited: 7
Neuromodulation of cognition in Parkinson's disease
Rachel C. Cole, Derrick Okine, Brooke E. Yeager, et al.
Progress in brain research (2022), pp. 435-455
Open Access | Times Cited: 12
Rachel C. Cole, Derrick Okine, Brooke E. Yeager, et al.
Progress in brain research (2022), pp. 435-455
Open Access | Times Cited: 12
Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
(2023)
Open Access | Times Cited: 6
Yıldız Değirmenci, Efthalia Angelopoulou, Vasiliki Georgakopoulou, et al.
(2023)
Open Access | Times Cited: 6
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
Amalia Perna, Kathleen S. Montine, Lon R. White, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1641-1652
Open Access | Times Cited: 6
Amalia Perna, Kathleen S. Montine, Lon R. White, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 6, pp. 1641-1652
Open Access | Times Cited: 6
Driving in Parkinson Disease
Maud Ranchet, Hannes Devos, Manuchair Ebadi
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 141-148
Open Access | Times Cited: 15
Maud Ranchet, Hannes Devos, Manuchair Ebadi
Clinics in Geriatric Medicine (2019) Vol. 36, Iss. 1, pp. 141-148
Open Access | Times Cited: 15
Deciphering the dual role of N-methyl-D-Aspartate receptor in postoperative cognitive dysfunction: A comprehensive review
Shaodi Guan, Yali Li, Yueyang Xin, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176520-176520
Open Access | Times Cited: 1
Shaodi Guan, Yali Li, Yueyang Xin, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176520-176520
Open Access | Times Cited: 1
NIR-II light therapy improves cognitive performance in MPTP induced Parkinson's disease rat models: A preliminary experimental study
Jiangong Zhang, Qinqin Zhu, Xun Shi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32800-e32800
Open Access | Times Cited: 1
Jiangong Zhang, Qinqin Zhu, Xun Shi, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32800-e32800
Open Access | Times Cited: 1
Molecular basis of the development of Parkinson’s disease
Margarita T. Absalyamova, Dmitrii S. Traktirov, Viktoria Burdinskaya, et al.
Neuroscience (2024) Vol. 565, pp. 292-300
Closed Access | Times Cited: 1
Margarita T. Absalyamova, Dmitrii S. Traktirov, Viktoria Burdinskaya, et al.
Neuroscience (2024) Vol. 565, pp. 292-300
Closed Access | Times Cited: 1
Current concepts in treating mild cognitive impairment in Parkinson's disease
Jay S. Schneider, Sandhya Kortagere
Neuropharmacology (2021) Vol. 203, pp. 108880-108880
Closed Access | Times Cited: 11
Jay S. Schneider, Sandhya Kortagere
Neuropharmacology (2021) Vol. 203, pp. 108880-108880
Closed Access | Times Cited: 11
